Platelet indices can be used to monitor the progression and outcomes of sepsis, including recovery or death, in neonates and children.
NOT BSTOTAL BS
HARDLY BS — Verdict: Mostly True
Verified by Lenz ·
The Short Version
A large body of observational studies and meta-analyses consistently shows that platelet indices (MPV, PDW, PCT, and their ratios) differ significantly between survivors and non-survivors in neonatal and pediatric sepsis, supporting the claim's core assertion. However, the overall certainty of evidence has been rated "very low" by at least one meta-analysis, discriminatory performance is modest (e.g., AUC of 0.708 for PDW), and no major clinical guidelines currently endorse these indices as standard monitoring tools. The claim is directionally accurate but overstates clinical readiness.
Caveats
The overall certainty of evidence for platelet indices in neonatal sepsis has been rated 'very low' by meta-analysis, and no large-scale randomized controlled trials have confirmed causality.
At least one study found no significant difference in MPV or PDW between pediatric survivors and non-survivors, and the best-performing index achieves only modest discriminatory performance (AUC ~0.71, sensitivity ~64%).
No major clinical guidelines from organizations such as the WHO or CDC currently endorse platelet indices as standard tools for monitoring sepsis progression or predicting outcomes in neonates and children.